Blood News and Research

RSS

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

A new multi-targeted anticancer drug called SU11248 has shown very promising results in the treatment for metastatic renal cell cancer, one of the most chemotherapy resistant of all cancers.

6 Jun 2004

Velcade major improvement over standard therapy for relapsed multiple myeloma

Early results from a major, international Phase III clinical trial decisively show that recurrent multiple myeloma is more effectively treated with the drug bortezomib (trade name: Velcade TM) than with dexamethasone, a drug that for decades has been the standard therapy for relapsed disease, researchers at Dana-Farber Cancer Institute report.

6 Jun 2004

Overweight families unaware & unconcerned about risk of diabetes and premature heart disease

Two new studies show that many children are at high risk for diabetes and premature heart disease, according to British and U.S. reports here today at the American Diabetes Association's 64th Annual Scientific Sessions.

5 Jun 2004

Research seeks best mix of hope and care for leukaemia sufferers

Funding has been granted for research seeking the best care options for patients with leukaemia and other blood disorders and their families.

5 Jun 2004

New method for identifying proteins found in trace quantities in the blood

Using conventional technologies, researchers supported by the National Cancer Institute (Science Applications International Corporation-Frederick, Inc. (SAIC)) have developed a new method for identifying proteins found in trace quantities in the blood.

5 Jun 2004

Depression, insulin regimen linked to poor diabetes control

In the largest study of diabetes and depression conducted to date, researchers at Duke University Medical Center have found a clear link between the complexity of the self-care regimens in patients with diabetes and the effect of depression on diabetes control.

5 Jun 2004

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have presented detailed 30-week data from two of the three pivotal Phase 3 studies of exenatide during a late-breaking session at the American Diabetes Association's (ADA) 64th Scientific Sessions in Orlando, Florida.

5 Jun 2004

New advice to doctors on lowering diabetes-heart disease risks

Every year, the American Diabetes Association (ADA) issues Clinical Practice Recommendations, a series of updated recommendations, to help health care providers treat people with diabetes using the most current research available.

5 Jun 2004

Diabetics could be up to three times more likely to get bowel cancer

People with diabetes could be up to three times more likely to get bowel cancer – according to a report from Cancer Research UK and the Medical Research Council published*(1) today.

5 Jun 2004

Polycystic ovary syndrome more common than originally thought

Researchers at Cedars-Sinai Medical Center and the University of Alabama, Birmingham, have found that a complex hormonal disorder affecting the reproductive and metabolic function of premenopausal women may be considerably more common in the United States than previously believed from earlier, smaller studies.

5 Jun 2004

People with diabetes could be up to three times more likely to get bowel cancer

Scientists tested a marker of the sugar levels in blood samples*(2) taken from almost 10,000 men and women aged between 45-79 and then checked their medical condition six years later.

5 Jun 2004

Parents oblivious to their children's weight problems

5 Jun 2004

UK's Hepatitis C ex-gratia payment scheme to launch

The Skipton Fund, the body set up to administer the UK-wide ex gratia payment scheme for people infected with Hepatitis C from NHS blood or blood products, will launch and begin processing applications on July 5 2004.

3 Jun 2004

Breakthrough in gene therapy

Despite a roller-coaster ride of ups and downs during the past 15 years, gene therapy has continued to attract many of the world's brightest scientists. They are tantalized by the enormous potential that replacing missing genes or disabling defective ones offers for curing diseases of many kinds.

3 Jun 2004

Drug helps patients with metastatic colorectal cancer

A drug designed to cut off a tumor’s blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended in patients with this devastating form of advanced cancer.

3 Jun 2004

Umbilical cord blood and bone marrow transplants slow the progression of many cancers

Umbilical cord blood and bone marrow transplants at Loyola University Health System, Maywood, Ill., are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, myeloma) or lymphatic system (lymphoma).

3 Jun 2004

150 top scientists debate and offer expert advice on cutting edge vaccine research

More than 150 top scientists, researchers and public health experts from around the world will meet in Switzerland next week to present, debate and offer expert advice on cutting edge vaccine research and development, as well as vaccine policy and implementation.

3 Jun 2004

Trial to beat cholesterol with soy and dairy combo

Researchers in the joint Adelaide Uni / UniSA Nutritional Physiology Research Group are looking for people to take part in a trial to see if combination low-fat dairy and soy foods will have an impact on reducing cholesterol and be more appealing to consumers.

3 Jun 2004

BMA to publish an A to Z of Doctors Making a Difference

The British Medical Association will today (Thursday 3 June 2004) publish an A to Z of Doctors Making a Difference. This UK-wide report illustrates how doctors are leading developments to increase patient care, improve access to services and enhance the patient experience.

3 Jun 2004

Drug to extend lives of colorectal cancer patients

A drug designed to cut off a tumor's blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended in patients with this devastating form of advanced cancer.

2 Jun 2004